Overcoming intractable diseases
with “Regeneration-Inducing Medicine

StemRIM is a biotechnology company aiming to develop a next generation of regenerative medicine,
“Regeneration-Inducing Medicine”.

Overcoming intractable diseases
with “Regeneration-Inducing Medicine

StemRIM is a biotechnology company aiming to develop a next generation of regenerative medicine,
“Regeneration-Inducing Medicine”.

IR News

February 29, 2024 Timely Disclosure Information StemRIM Announces Fixed Details of the Issuance of Stock Options to External Collaborators 
February 15, 2024 Timely Disclosure Information StemRIM Announces Patent Registration (Japan) for the Use of the HMGB1 Fragment Peptide, Redasemtide, as an Additional Therapeutic Indication of Traumatic Cartilage Deficiency Syndrome, Osteoarthritis, and Disseverance Osteochondritis 
February 14, 2024 Timely Disclosure Information StemRIM Announces Issuance of Stock Acquisition Rights as Stock Options to External Collaborators 
January 31, 2024 Timely Disclosure Information StemRIM Announces Patent Registration (Russia) for the Use of the HMGB1 Fragment Peptide, Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders (Traumatic Cartilage Deficiency Syndrome, Osteoarthritis, Disseverance Osteochondritis, etc.) 
December 28, 2023 Timely Disclosure Information StemRIM Announces Fixed Details of the Issuance of Stock Options to External Collaborator 
IR News Here

NEWS Release

April 25, 2023 NEWS Release
News Release Here

Video

Video Here

We aim to bring a happy future to patients suffering from intractable diseases.

StemRIM is a biotechnology company aiming to develop a next generation of regenerative medicine, “Regeneration-Inducing Medicine”.
“Regeneration-Inducing Medicine” is an innovative new class of medicine that induces functional regeneration of tissues and organs in the patient's body by maximizing the human body's innate ability of tissue repairing.
We are pursuing research and development of new drugs based on a novel mechanism of action leading to recruitment of the patients’ own in-vivo stem cells to the damaged tissues for functional tissue regeneration without conventional cell-therapy approaches.

What is “Regeneration-Inducing
Medicine”?
Issues of Conventional
Cell Therapy
The Superiority of
“Regeneration-Inducing Medicine

Business

Corporate Information Investor Relations